Sable Offshore

RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced results from the Phase 3 KEYNOTE-689 trial evaluating KEYTRUDA® (pembrolizumab), Merck's anti-PD-1 therapy, as a perioperative treatment regimen for patients with stage III or IVA, resected, locally advanced head and neck squamous cell carcinoma (LA-HNSCC). Results at the first interim analysis of the trial showed KEYTRUDA significantly improved event-free survival (EFS) as pa.» Mehr auf businesswire.com

BURLINGTON, Mass.--(BUSINESS WIRE)--N‑able, Inc. (NYSE: NABL), a global software company delivering a unified cyber resiliency platform to manage, secure, and recover, today launched its first annual 2025 State of the SOC Report—exploring the trends shaping security operations through real-world insights from Adlumin Managed Detection and Response (MDR). The report explores the challenges SOCs face in adapting to an expanding attack surface, highlighting their vital role in enhancing cybersecur.» Mehr auf businesswire.com

Procare and ChildPlus software hold the prestigious SOC 2 Type 2 certification, a gold standard for secure and trustworthy data management DENVER , April 15, 2025 /PRNewswire/ -- Procare Solutions, a leader in child care management software, is pleased to announce that ChildPlus, a Procare Solutions company serving Head Start providers, has also received the distinction of being SOC 2 Type 2 compliant by taking steps far beyond what is required by law to secure data. Procare Solutions stands out as one of the few U.S.-based child care management software providers with exceptional data security credentials.» Mehr auf prnewswire.com